La Bodies Eclipse Sunscreen Spf 30 Lotion
NDC Package 20146-4007-2
Package Information
La Bodies Eclipse Sunscreen Spf 30 (avobenzone, homosalate, octisalate, octocrylene, and oxybenzone) lotions is apply generously and evenly to all areas 15 minutes before sun exposurereapply at frequent intervals and after swimming or towel dryingask a doctor before use on children under six months of age. This formulation utilizes a lotion delivery system. Marketed by Samson Pharmaceutical, this product is identified by NDC 20146-4007 and is authorized under FDA application M020.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 20146 - Samson Pharmaceutical
- 20146-4007 - La Bodies Eclipse Sunscreen Spf 30
- 20146-4007-2 - 85 g in 1 TUBE
- 20146-4007 - La Bodies Eclipse Sunscreen Spf 30
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (20146-4007). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 20146-4007-2 identifies a specific commercial package of 85 g in 1 tube of La Bodies Eclipse Sunscreen Spf 30, a human over the counter drug labeled by Samson Pharmaceutical. This lotion is formulated for topical use and contains avobenzone; homosalate; octisalate; octocrylene; oxybenzone as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Samson Pharmaceutical on January 01, 2015. The current certification is valid through December 31, 2026.
How is this Samson Pharmaceutical product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 20146400702. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.